- Fee assured
- Verified this account
- Inflammatory bowel disease
Dr Shariff is a trained specialist in gastroenterology, liver and pancreatic disease and his NHS practice is based at West Hertfordshire Hospitals NHS Trust where he is Clinical Lead for Gastroenterology. He is also an Honorary Consultant at the Royal Free Hospitals Foundation Trust where he practices Hepatology (Liver medicine). He enjoys all aspects of gastroenterology including dyspepsia, irritable bowel syndrome and diarrhoea and has a sub-speciality interest in liver and pancreatic disease. He also practices basic and advanced endoscopy including gastroscopy, colonoscopy, ERCP and endoscopic ultrasound.
In the outpatient clinic, Dr Shariff takes time and care to understand your symptoms and has previously received excellent feedback from patients and colleagues. He is an accredited endoscopist (JAG) and has very good colonoscopy comfort scores.
Dr Shariff qualified in 2001 from Oxford University where he was awarded a prestigious Nuffield Scholarship in Medicine and undertook his postgraduate clinical training at the Hammersmith, King’s College and Royal London hospitals. In 2008, he was appointed as a Clinical Research Fellow at Imperial College and awarded a PhD in 2012. He has published a number of articles in peer reviewed journals and presented research at National and International conferences. He maintains an active interest in clinical research, with a focus upon liver and pancreatic disease.
Areas of interest
General gastroenterology; abdominal pain; dyspepsia; diarrhoea; liver disease; viral hepatitis; pancreatic disease; EUS; ERCP
Current NHS consultant posts held
West Hertfordshire NHS Trust
Watford General Hospital
In his free time, he enjoys spending time with his family is a classical guitarist and enjoys playing tennis, cricket and squash.
2009- Association of Physicians of Great Britain and Ireland Highlighted poster award
2009- European Association of the Study of the Liver bursary award for presentation at the Liver Congress
1997- Nuffield Scholar in Medicine, Oxford University
(Additional) Languages spoken
Shariff MI, Khan SA, Westaby D. The Palliation of Cholangiocarcinoma. Curr.Opin. Support. and Palliat. Care. February 2013.
Shariff MI, Maggs J, Heneghan MA. Mortality and the risk of malignancy in autoimmune liver diseases: A population-based study in Canterbury, New Zealand. Hepatology Letter 2012.
Patel M, Shariff MI, Ladep NG, Thillainayagam AV, Thomas HC, Khan SA, Taylor-Robinson SD: Hepatocellular carcinoma: diagnostics and screening. J.Eval.Clin.Pract. 2012, 18:335-342.
Shariff MI, Gomaa AI, Cox IJ, Patel M, Williams HR, Crossey MM, Thillainayagam AV, Thomas HC, Waked I, Khan SA, Taylor-Robinson SD: Urinary Metabolic Biomarkers of Hepatocellular Carcinoma in an Egyptian Population: A Validation Study. J.Proteome.Res. 2011, 10:1828-1836.
Shariff MI, Ladep NG, Cox IJ, Williams HR, Okeke E, Malu A Thillainayagam AV, Crossey MM, Khan SA, Thomas HC, Taylor-Robinson SD. Characterization of urinary biomarkers of hepatocellular carcinoma using magnetic resonance spectroscopy in a nigerian population. J Proteome Res 2010 5;9(2):1096-103.
Shariff MI, Cox IJ, Gomaa AI, Khan SA, Gedroyc W, Taylor-Robinson SD: Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert.Rev.Gastroenterol.Hepatol. 2009, 3:353-367.
Shariff MIF and Taylor-Robinson SD. Dipstick markers for diagnosis: Feasible or not? Clinical Dilemmas in Primary Liver Cancer. Wiley publishing, December 2011.
Courses offered to GPs
- BMBCh Oxford University 2001
- MRCP Royal College of Physicians 2004
- PhD Imperial College London 2011
Reference number 6030041
Details of entry to specialist register
- Entry into Specilist Registry, 2013
Affiliations / memberships
British Society of Gastroenterology; British Association for the study of the liver
- Spire Bushey Hospital, WD23 1RD
- 18:00 - 21:00
- 020 8950 9090
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details